GLOW Stack vs Wolverine Stack: What the Extra GHK-Cu Changes

The GLOW Stack costs $86.40 and the Wolverine Peptide Stack costs $40.80 at Real Peptides, and the entire $45.60 gap pays for one thing: a 50 mg vial of GHK-Cu. The BPC-157 10 mg and TB-500 10 mg vials are the same in both bundles. So the real question behind choosing a glow peptide stack over Wolverine is whether your research needs the copper peptide at all.

We compare these bundles from the supply side, looking at contents, per-milligram price, testing and regulatory status. Both are sold for research use only. None of the peptides in either box is an FDA-approved drug, and neither stack has been tested as a combination in controlled human trials.

The only difference is a 50 mg GHK-Cu vial

Wolverine is BPC-157 plus TB-500; GLOW is BPC-157 plus TB-500 plus GHK-Cu. "Wolverine stack" is the popular name for that two-peptide pair across the market, and "GLOW" is Real Peptides' marketing name for the three-peptide version.

Because the shared vials are identical in size, the glow peptide stack is not a stronger or different version of Wolverine. It is Wolverine with an extra compound that has its own research history, mostly in skin, wound and collagen models.

Side by side: contents, price and per-mg cost

On a per-milligram basis the glow peptide stack is cheaper, but only because the GHK-Cu vial is large. Here are both bundles plus the Peptide God blend, which is the other BPC-157 and TB-500 option we track.

If you only count the two shared peptides, Wolverine is the better buy: you get the same 20 mg for $40.80. GLOW only wins on value if the GHK-Cu vial is something you would otherwise buy. Our cost page runs these numbers with shipping included.

What GHK-Cu brings to the research picture

GHK-Cu adds a research area that BPC-157 and TB-500 do not cover: skin, wound and collagen models. It is a copper-binding tripeptide found naturally in human plasma, and its levels fall with age.

Most GHK-Cu work is lab and animal research, with small cosmetic studies on topical products. That is a narrow base, and the cosmetic studies concern creams and serums rather than research vials. If you want the detail, our GHK-Cu peptide guide covers it, and GHK-Cu vs BPC-157 lines it up against the best known part of Wolverine.

The regulatory gap between the two stacks

Every compound in the Wolverine stack received a panel recommendation in July 2026; the extra compound in GLOW did not. On 23 July 2026, FDA's Pharmacy Compounding Advisory Committee voted 8-6, with one abstention, to recommend BPC-157 and TB-500 for the 503A bulks list.

GHK-Cu was not on that agenda. It is scheduled for committee review before February 2027. In practice that changes little today, since none of the three has been added to the list and the votes are non-binding. It does mean the GLOW Stack has one more open regulatory question than Wolverine. Both stacks share the sport problem: BPC-157 and TB-500 are on the WADA Prohibited List.

Which bundle fits which research question

Choosing between the glow peptide stack and Wolverine comes down to scope. We would frame it like this:

• Wolverine Peptide Stack fits work that only concerns BPC-157 and TB-500. It is the cheapest way into both peptides from one vendor and one lot, though stock can sell out during high demand.
• GLOW Stack fits work that also needs GHK-Cu, and you want all three vials documented by one vendor's COAs in a single order.
• BPC-157 + TB-500 Blend fits buyers who prefer Peptide God's terms, such as free shipping over $100 and 30-day free returns, and who accept a single blended vial with a fixed ratio.

None of these is a product for personal use, and we do not publish preparation or dosing material for any of them. For a full vendor view, including COA checks, see where to buy glow peptide.